MIRA Pharmaceuticals, Inc.
MIRA
$1.41
-$0.01-0.70%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -74.13% | -65.81% | -38.45% | -29.37% | 11,286.29% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -5.71% | -14.41% | -77.56% | -57.30% | 155.53% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -71.60% | -63.25% | -40.56% | -30.31% | 597.03% |
|
|||||
Total Current Assets | -71.60% | -63.25% | -40.56% | -30.31% | 597.03% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -57.45% | -62.14% | -48.84% | -98.75% | -97.46% |
Total Assets | -71.21% | -63.24% | -40.74% | -52.69% | -21.16% |
|
|||||
Total Accounts Payable | -61.83% | -84.17% | 34.29% | -11.13% | 18.66% |
Total Accrued Expenses | -- | -62.07% | -- | -- | -63.38% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -62.53% | -83.71% | 29.60% | -20.22% | -69.09% |
|
|||||
Total Current Liabilities | -62.53% | -83.71% | 29.60% | -20.22% | -69.09% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -62.53% | -83.71% | 29.60% | -23.27% | -69.69% |
|
|||||
Common Stock & APIC | 22.72% | 23.15% | 22.13% | 28.37% | 105.34% |
Retained Earnings | -31.44% | -34.42% | -36.89% | -72.53% | -107.34% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -74.32% | -59.00% | -49.71% | -55.96% | 85.44% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -74.32% | -59.00% | -49.71% | -55.96% | 85.44% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -74.32% | -59.00% | -49.71% | -55.96% | 85.44% |
|